Showing results (81-90 of 101) with videos related to
Sort By:
Pageof 11
Hepatology International|January 9, 2021
Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosisJean-Frédéric Blanc, Faiza Khemissa, Jean-Pierre Bronowicki, et al.Gastrointestinal Endoscopy|February 19, 2026
Ability of computed tomography and endoscopic ultrasound to predict pTNM of resected ampullary adenocarcinomas (AC): an analysis of the French Fédération Française de Cancérologie Digestive AC prospective cohort studyAnna Pellat, Sylvain Manfredi, Stéphanie Truant, et al.European Journal of Cancer (Oxford, England : 1990)|May 29, 2018
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trialsThomas Aparicio, Michel Ducreux, Roger Faroux, et al.International Journal of Cancer|January 9, 2020
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patientsThomas Aparicio, Julie Henriques, Sylvain Manfredi, et al.JHEP Reports : Innovation in Hepatology|February 3, 2025
First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: The French ACABi GERCOR PRONOBIL cohortNicolas Adamus, Julien Edeline, Julie Henriques, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|December 13, 2017
Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver MetastasesFrançois Tranquart, Paul-Armand Dujardin, Olivier Bouché, et al.Frontiers in Oncology|November 28, 2022
Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancerAdrien Grancher, Ludivine Beaussire, Sylvain Manfredi, et al.The Lancet. Gastroenterology & Hepatology|June 22, 2026
Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trialPhilippe Merle, Jean-Frederic Blanc, Karine Le Malicot, et al.Journal of Hepatology|May 25, 2019
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinomaJean-Louis Jouve, Thierry Lecomte, Olivier Bouché, et al.British Journal of Cancer|May 14, 2024
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databasesThomas Aparicio, Julie Henriques, Magali Svrcek, et al.Pageof 11